A Division of Alkhaleeli BioAI LLC

SciNova Research Press

Where Scientific Ideas Become Discoverable Knowledge

Advancing Discovery. Preserving Knowledge. Inspiring Innovation.

Explore research, publications, computational discoveries, and scientific innovations developed through Alkhaleeli BioAI LLC.

9
Publications
5
Categories
9
DOI Works
2
Open Access

Featured Publications

SciNova Research Press showcases interdisciplinary research at the intersection of artificial intelligence, microbiology, immunology, vaccine design, computational biology, and drug discovery.

All publications
Vaccine and Immunoinformatics ResearchPreprintPreprintRestricted

Alkhaleeli, Rami (2026). In Silico Prioritization of a Hantavirus Glycoprotein-Derived Multi-Epitope mRNA Vaccine Candidate Using the Rami Five-Checkpoint Framework. [Preprint]. Zenodo. DOI: 10.5281/zenodo.20099929.

This preprint presents a purely in-silico computational study evaluating the Hantavirus CGRn8316 glycoprotein as a potential mRNA vaccine antigen. The Rami Five-Checkpoint Framework was applied to compare the full-length glycoprotein with a shorter trimmed multi-epitope construct, scoring antigen selection, sequence optimization, RNA design feasibility, epitope-like immunogenicity, and cost/scalability.

HantavirusmRNA vaccinein silico vaccine designcomputational vaccinology
33 views 8 downloads
Vaccine and Immunoinformatics ResearchPreprintPreprintOpen Access

Alkhaleeli, Rami (2026). mRNA Multi-Epitope Vaccine Design Against Zaire Ebolavirus. [Preprint]. Zenodo. DOI: 10.5281/zenodo.18133430.

This work presents the computational design of a multi-epitope mRNA vaccine candidate against Zaire ebolavirus using an immunoinformatics-driven approach. Conserved regions from the Ebola glycoprotein (GP), nucleoprotein (NP), and matrix protein VP40 were analyzed to identify high-affinity CD8+ and CD4+ T-cell epitopes.

Zaire ebolavirusEbola virusmRNA vaccineMulti-epitope vaccine
131 views 79 downloads
Books and Scientific MonographsBookOpen Access

Alkhaleeli, Rami et al. (2025). AI as Humanity's Second Immune System: A Comprehensive Guide to AI-Driven Vaccine Development and Precision Medicine. [Book]. Zenodo. DOI: 10.5281/zenodo.17577320.

This book presents a unified conceptual and computational framework that envisions Artificial Intelligence (AI) as an extension of humanity's adaptive immune system. Through advanced in-silico modeling, the work demonstrates how machine learning and bioinformatics pipelines can emulate immune recognition, predict antigenic targets, and generate mRNA-based vaccine and tolerance candidates.

AI medicinecomputational immunologymRNA vaccinebioinformatics
420 views 310 downloads

Publishing Process

The exact review method and publication status is disclosed for every manuscript.

1
Manuscript Submission
2
Administrative Screening
3
Scientific and Formatting Review
4
Author Revisions
5
Editorial Decision
6
DOI and Repository Preparation
7
Online Publication
8
Research Promotion and Archiving

Editorial Integrity

Scientific transparency is fundamental to SciNova Research Press. Every published record must clearly identify whether it is a preprint, technical report, independently reviewed manuscript, book, or formally peer-reviewed article.

Read editorial standards

Submit Your Scientific Manuscript

SciNova Research Press welcomes original scientific manuscripts, computational studies, technical reports, reviews, hypotheses, protocols, and interdisciplinary research.

Begin Manuscript Submission
Alkhaleeli BioAI LLC
Computational Biotechnology & AI Research

An Oklahoma-based computational biotechnology company advancing biomedical innovation through artificial intelligence, bioinformatics, and mathematical science.

Oklahoma City, Oklahoma, USA

Legal

In-silico research only. No wet-lab, animal, or human testing. Educational and computational focus.

Important Disclaimer

Alkhaleeli BioAI LLC provides computational, educational, and research-oriented services only. All vaccine, therapeutic, protein, biosensor, and biomedical concepts described on this website are in-silico models and theoretical frameworks. They are not medical products, are not intended for clinical use, and have not been validated through wet-lab, animal, or human testing. Nothing on this website should be interpreted as medical advice, clinical guidance, regulatory approval, or a claim of safety or efficacy.

Alkhaleeli BioAI LLC provides educational, research-focused, publishing-support, and digital content tools. Content and AI tools are not medical, legal, financial, regulatory, or clinical advice. All submitted content is subject to review before publication. Alkhaleeli BioAI LLC reserves the right to reject, remove, refund, or suspend any content that violates safety, legality, copyright, originality, or professional standards.

© 2026 Alkhaleeli BioAI LLC. All rights reserved. Research Publishing & Royalty Platform.